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METHODS The MECHANISM-AMI study is designed to elucidate early vascular responses of EES for STEMI patients using optical coherence tomography (OCT). Patients were prospectively registered in either 2week (2W) or 3-month scheduled OCT follow-up cohort. Among them, 2W cohort could be completely analyzed, that is the subject of current study. In addition to standard OCT parameters, intra-stent thrombus was quantitatively analyzed in terms of the maximal area and %length of thrombus (the numbers of cross-section with thrombus Â 100 divided by total number of cross-sections within the stented segment).
RESULTS
A total of 53 patients (age: 64.0AE11.8 years, male: 84.9%) were enrolled in this study from 14 sites. A total of 44 patients were considered available for complete serial OCT analyses due to image quality, although entire cases completed OCT observation at both sequences. Average stent length was 23.6AE8.0 mm. Both %uncovered struts and %malapposed struts significantly improved from postprocedure to 2W follow-up (%uncovered struts: 61AE19 % vs 20AE13 %, p<0.0001, %malapposed struts: 7.2AE9.1 % vs 4.6AE6.0 %, p¼0.006, respectively). Amount of intra-stent thrombus significantly decreased from post-procedure to 2W follow-up (%length: 33AE37 % vs 17AE18 %, p¼0.003, average maximal area of thrombus: 0.62AE0.74 mm 2 vs 0.11AE0.23 mm 2 , p¼0.0002, respectively). Similarly, number of dissection flap greater than 200 mm also significantly decreased (0.90AE1.12 vs 0.57AE0.91, p¼0.03, respectively).
CONCLUSIONS The MECHANISM-AMI study 2W cohort firstly elucidated very early vascular responses following EES implantation in STEMI patients. Vascular healing processes begin in such a very early stage, including covered struts of nearly 80%, improvement of strut apposition and dissection flap size, and a significant reduction of intra-stent thrombus volume within 2 weeks. These meticulous findings may potentially explain the underlying mechanisms of safety and efficacy of EES for STEMI patients, supporting the favorable outcomes observed in the previous clinical studies. BACKGROUND A recent validation study reported an overestimation in lumen measurements by IVUS compared with optical coherence tomography (OCT). However, there remains a theoretical concern that practical differences in image data processing and system configurations may lead to considerable variability in quantitative precision, even within the modalities utilizing the same technical principles. This study aimed to provide head-to-head comparison of the quantitative accuracy among contemporary intravascular imaging systems currently available in the catheterization laboratory.
METHODS Five coronary models with known lumen diameters (1.51-5.04 mm) were imaged using 2 OCT and 4 IVUS systems: 1) optical frequency domain imaging (OFDI, FastView, Terumo), 2) Fourier-domain OCT (FD-OCT, Dragonfly JP, St. Jude Medical), 3) 40-MHz mechanical IVUS (ViewIT, Terumo), 4) 40-MHz mechanical IVUS (OptiCross, Boston Scientific), 5) 45-MHz mechanical IVUS (Revolution, Volcano), and 6) 20-MHz solid-state IVUS (Eagle Eye Platinum, Volcano). To standardize the conditions, all catheter imagings were performed coaxially in a saline-filled tank at 37 C, and IVUS measurements were adjusted to compensate for the difference in the speed of sound in saline vs. blood. OFDI and FD-OCT images were obtained under the system setting for saline flush. In each diameter phantom model, mean lumen diameter (LD) was obtained at 10 randomly selected cross-sections.
Overall, OFDI, FD-OCT, and 40-MHz IVUS (ViewIT) showed slight overestimation in mean LD (0.02AE0.02, 0.01AE0.02, and 0.02AE0.02 mm, respectively). While another 40-MHz IVUS (OptiCross) showed a moderate degree of overestimation (0.16AE0.03 mm, P<0.001), 45-MHz IVUS (Revolution) and 20-MHz IVUS (Eagle Eye Platinum) exhibited underestimation (-0.05AE0.03 mm, P<0.001, and -0.03AE0.03 mm, P<0.001, respectively). In both OCT and IVUS, the degrees of over-or underestimation varied depending on the phantom diameter (figure), presumably due to the focus setting of each system.
CONCLUSIONS This validation study warranted clinically acceptable quantitative precision in all systems. On the other hand, some systematic variability was observed among the systems and phantom diameters, which requires attention when using multiple imaging systems for serial examinations or comparative studies.
